Click to go to DrugInjuryLaw Home


Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation Zocor Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation Gianvi Case Evaluation


Free Case Evaluation

Gianvi Information (Visit Our New Site >>)

What is Gianvi?

Gianvi, a generic version of YAZ, is from Teva Pharmaceuticals and Barr Laboratories.

Gianvi birth control pills contain ethinyl estradiol and the new "fourth generation" progestin drospirenone (DRSP).

Other birth control pills, or oral contraceptives, which contain ethinyl estradiol and drospirenone are:

YAZ and Yasmin from Bayer HealthCare Pharmaceuticals, Inc.; and,

Ocella from Teva Pharmaceuticals and Barr Laboratories.

In addition, there are Beyaz, which contains the same estrogen-progestin combination as YAZ plus 0.451 mg of levomefolate calcium, and Safyral, which contains the same estrogen-progestin combination as Yasmin plus 0.451 mg of levomefolate calcium.  These DRSP / drospirenone-containing birth control pills are from Bayer HealthCare Pharmaceuticals, Inc.

These birth control pills with DRSP have been associated with various adverse side effects, such as: 

  • Blood Clots
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Stroke
  • Cerebrovascular Accidents (CVA)
  • Heart Attack
  • Myocardial Infarction
  • Death

 

Ten Most Recent Gianvi Case Evaluations

Gianvi - Pulmonary Embolism (PE) - 25 yr old woman (7999)

Gianvi - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 28 yr old woman (7900)

Gianvi - Deep Vein Thrombosis (DVT) - 28 yr old woman (7893)

Gianvi - Pulmonary Embolism (PE) - 22 yr old woman (7871)

Gianvi - Deep Vein Thrombosis (DVT); blood clot calcified, will alwawys be in the vein - 32

yr old woman (7870)

Gianvi - Deep Vein Thrombosis (DVT) - 19 yr old woman (7869)

Gianvi - Pulmonary Embolism (PE) - 21 yr old woman (7804)

Gianvi - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 21 yr old woman (7744)

Gianvi - Deep Vein Thrombosis (DVT) with subsequent fatal Heart Attack / Myocardial

Infraction (MI) secondary to Pulmonary Embolism (PE) - 48 yr old woman (7711)

Gianvi - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 23 yr old woman (7691)

 




Free Gianvi Case Evaluation

The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day.  Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit.  We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.

 



Gianvi (Generic YAZ), Beyaz, And Safyral Causing Blood Clots In Lung (PE) Or Legs (DVT) Are Cases That Can Get Settlements

While the YAZ / Yasmin / Ocella birth control pill lawsuits against Bayer have received more attention in the past few years, it is important to know that Gianvi, Beyaz, and Safyral cases involving blood clots can get settlments, too.

 

YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Beyaz / Safyral:  Serious Side-Effects Lawsuit News And Information Hub

This is an up-to-date collection of drug injury lawyer blog posts and selected news articles regarding legal claims involving YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Beyaz / Safyral birth control pills.

 

Ocella, Yasmin, YAZ, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Can Cause Pulmonary Embolism, Deep Vein Thrombosis, Stroke, And Heart Attack

Some medical journal articles are linking certain oral contraceptives, such as Ocella, Yasmin, Zarah, Syeda, YAZ, Gianvi, Loryna, Beyaz, and Safyral to pulmonary embolism (PE) and deep vein thrombosis (DVT). These birth control pills each contain drospirenone (DRSP), a unique progestin which causes an increased risk of thromboembolism, or blood clot, side effects when compared to older oral contraceptives (OCs). Estrogen and DRSP create a potentially life-threatening combination due to their coagulative effects.

How And Why YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Pills Might Cause A Higher Rate Of Blood Clots In Women

All hormonal birth control options are associated with some health risks. However, the oral contraceptive pills YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral have the distinction of being associated with a possible higher rate of blood clots which can cause serious side effects – namely, stroke, heart attack, pulmonary embolism, and deep vein thrombosis. The obvious questions are “How?” and “Why?”.

Are The Current Warnings About Blood Clot Side Effects Associated With YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Beyaz, And Safyral Sufficient?
Although the package inserts for YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral carry a bolded warning for the increased risk of hyperkalemia associated with these birth control pills, any warnings for the associated blood clot risks are found in only regular print. Now lawsuits are being filed on behalf of women who used these birth control pills alleging there has been a failure to warn about the increased risk of blood clots.

Oral Contraceptives Such As YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Found To Increase The Risk For Gallbladder Disease
Increasingly, medical studies are finding a clear and formidable link between hormonal contraceptive pills like YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral and gallbladder complications. These gallbladder injuries, such as acute cholecystitis, often end in gallbladder removal surgery, or cholecystectomy.

Pulmonary Embolism And Deep Vein Thrombosis: Symptoms, Treatment, and Recovery

For women who are using estrogen-progestin methods of birth control -- such as YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral -- here is some important information about symptoms, treatment and recovery from a blood clot, which is a serious, potentially fatal side effect of these birth control products.


YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Class Actions
We believe that people who suffered a serious injury or death due to the YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral oral contraceptive pills are better served when an individual lawsuit is filed on their behalf. A serious injury or death case should not be filed as part of any YAZ, Yasmin, Ocella, Gianvi, Loryna, Syeda, Zarah, Beyaz, or Safyral class action together with the claims of many other people who may have had different injuries caused by these birth control pills.

Legal Compensation for YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Injuries
If you experienced serious side effects from the use of YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral, or a person died due to an adverse reaction while taking these birth control pills containing drospirenone (DRSP), you may have a claim for legal compensation. Legal compensation claims involving injuries or death caused by the use of YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral are made by filing a lawsuit in court. All states have statutes of limitations that determine the deadlines by which to file lawsuits involving these drospirenone (DRSP) oral contraceptives.

YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Beyaz / Safyral Information

YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral are popular birth control pills made with ethinyl estradiol (EE) and the new "fourth generation" progestin, or progesterone, drospirenone (DRSP). These four DRSP oral contraceptives have been associated with potentially fatal blood-clot side effects such as deep vein thrombosis (DVT), pulmonary embolism (PE), strokes, and heart attacks. Other associated serious side effects are gallbladder problems (cholecystitis) and gallbladder removal (cholecystectomy).

 
 



Drug Injury Watch: Gianvi News And Commentary

Higher Risk Of Venous Thrombosis - Blood Clot Side Effects Like DVT And PE With YAZ / Yasmin Birth Control Pills Is Confirmed By September 2013 BMJ Medical Journal Article


As With So-Called "Third Generation" Oral Contraceptives, For Drospirenone (DRSP) Containing Pills The Risk Is 50% To 80% Higher Than Levonorgestrel Pills

SUMMARY: The primary outcome of interest to the medical researchers who wrote this BMJ medical journal article was a fatal or non-fatal first event of venous thrombosis with their main focus on deep vein thrombosis (DVT) or pulmonary embolism (PE).

In the end, this new medical journal article serves to confirm the association of blood clot side effects like deep vein thrombosis (DVT) or pulmonary embolism (PE) with the DRSP birth control pills YAZ, Yasmin, Beyaz, Safyral, Ocella, and Gianvi.

[Read this article in full at original source]

 

Earlier Gianvi related articles by Tom Lamb on the Drug Injury Watch blog:

YAZ / Yasmin / Ocella / Gianvi Blood Clot Lawsuits That Are Not Settled Yet: Number Increases, Indicating That These Legal Claims Continue To Be Filed In 2013

Summer 2013 Bayer Lawsuits Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits Continue To Be Settled, With New Cases Being Filed

As Bayer Settlements For YAZ, Yasmin, Ocella, And Gianvi Continue In 2013, Total Payments Will Go Over The $1 Billion Level

Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe

November 2012 Litigation And Settlement Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits

2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots

Bayer Settlements: Gianvi / Ocella / Yasmin / YAZ: July 2012 Update On Drug Injury Lawsuits Filed To Date

Medical Study Finds Link Between YAZ / Yasmin And Irritable Bowel Syndrome (IBS) Coming From Drospirenone (DRSP) Progestin

Bayer Settlements For YAZ / Yasmin Lawsuits Involving Blood Clot Side Effects Like Deep Vein Thrombosis And Pulmonary Embolism

April 2012 Yasmin / YAZ Label Change: FDA Warns About Increased Risk Of Blood Clots Possible Due To Drospirenone

YAZ / Yasmin Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012

Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills

Gianvi Legal Claims Against Drug Company Still Possible Despite Mensing Case Rule Against Generic Drug Injury Lawsuits

YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More)

YAZ / Yasmin: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online

Another Generic YAZ Birth Control Pill Is Approved, Just One Week Before FDA Drug Safety Meeting

Two More Medical Studies Show Increased Risk Of Blood Clots With Use Of YAZ, Yasmin, And Ocella

YAZ / Yasmin / Ocella Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Like DVT, PE, Stroke, And Heart Attack

Women Who Used YAZ / Yasmin / Ocella Are Getting Letters From Aetna Medical Insurance Company

YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary Embolism


All content by attorney Tom Lamb




  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • DrugInjuryLaw.com is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535
email: ThomasJLamb@DrugInjuryLaw.com

Disclaimer